Fund HoldingsFairmount Funds Management LLC

Total Portfolio Value
$1.38B
Total Bought
$384.60M
Total Sold
$380.68M
Net Transaction
+$3.93M
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
DAMORA THERAPEUTICS INC(DMRA)08,713,000+8,713,0000225,66716.30%+225,667
DIANTHUS THERAPEUTICS INC(DNTH)2,137,1912,537,191+400,00088,074212,92115.38%+124,847
SPYRE THERAPEUTICS INC(SYRE)4,018,1014,018,1010131,633202,67314.64%+71,040
ORUKA THERAPEUTICS INC(ORKA)3,705,2623,705,2620112,306181,74313.13%+69,437
CRESCENT BIOPHARMA INC.2,747,8662,747,866032,59050,4783.65%+17,889
ENLIVEN THERAPEUTICS INC3,711,4441,855,644-1,855,80057,15672,7415.25%+15,585
INHIBIKASE THERAPEUTICS INC8,625,0008,625,000017,68114,4901.05%-3,191
JADE BIOSCIENCES INC4,553,4944,553,494070,26063,9774.62%-6,284
ZENAS BIOPHARMA INC(ZBIO)2,209,0252,359,025+150,00080,21046,1193.33%-34,091
VIRIDIAN THERAPEUTICS INC(VRDN)3,914,4583,914,4580121,81876,5675.53%-45,251
KINIKSA PHARMACEUTICALS INTL(KNSA)1,319,6880-1,319,68854,4370-54,437
NUVALENT INC(NUVL)727,5630-727,56373,1860-73,186
COGENT BIOSCIENCES INC(COGT)9,003,4185,503,418-3,500,000319,801211,82715.30%-107,975
APOGEE THERAPEUTICS INC(APGE)2,048,647298,647-1,750,000154,63225,1371.82%-129,495
Page 1 of 1